Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Hematology|May 20, 2018
Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencingShintaro Ono, Manabu Nakayama, Hirokazu Kanegane, et al.
The Journal of Biological Chemistry|January 2, 2003
Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein EKenta Magoori, Man-Jong Kang, Mitsuko R Ito, et al.
International Journal of Hematology|December 11, 2023
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myelomaAkio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, et al.
Annals of Hematology|November 27, 2019
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myelomaReiko Isa, Nobuhiko Uoshima, Ryoichi Takahashi, et al.
Cancer Science|July 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 PatientsTakahiro Kumode, Hitomi Sawa, Kohta Miyawaki, et al.
Bone Marrow Transplantation|October 4, 2025
Comparison of single-unit umbilical cord blood transplantation and haploidentical transplantation using posttransplant cyclophosphamide during first complete remission of acute myeloid leukemiaMasamitsu Yanada, Satoshi Yamasaki, Shohei Mizuno, et al.
Leukemia|November 24, 2021
Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemiaYoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, et al.
Cell Metabolism|February 4, 2009
Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2Iori Sakakibara, Takahiro Fujino, Makoto Ishii, et al.
International Journal of Hematology|January 24, 2022
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational studyYuka Kawaji-Kanayama, Ayako Muramatsu, Nana Sasaki, et al.
Leukemia & Lymphoma|March 26, 2025
Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective studyTakahiro Fujino, Haruya Okamoto, Daichi Nishiyama, et al.
Pageof 8